GlassScriptPhysician profile
Marguerite Thomer
NPI 1932375821
$6,844.73
in general payments reported to CMS, 2019-2025
41 companies · $2,224 in 2025
The $2,224 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $221 · 2021: $732 · 2022: $822 · 2023: $1,173 · 2024: $799 · 2025: $2,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,697 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,696.54 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $1,500.00 | 2025 | Npd Clinical Study |
| Procept Biorobotics Corporation | $703.26 | 2023-2025 | Aquabeam Robotic System |
| Astellas Pharma US INC | $571.98 | 2019-2025 | Myrbetriq, Xtandi |
| Coloplast Corp | $483.04 | 2019-2024 | Speedicath |
| Abbvie INC. | $451.08 | 2019-2025 | Lupron Depot, Botox |
| Boston Scientific Corporation | $431.00 | 2019-2024 | Solyx Sis System, Spaceoar Vue System - 10ml, Lithovue |
| Janssen Biotech, INC. | $292.69 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $283.49 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $248.90 | 2021-2024 | Aveed, Xiaflex |
| Teleflex LLC | $248.76 | 2021-2025 | Urolift, Solesta |
| Bioprotect Medical, INC. | $230.61 | 2025 | Bioprotect Balloon Implant System |
| Axonics, INC. | $202.39 | 2022-2023 | Axonics, Bulkamid |
| Urovant Sciences INC | $113.14 | 2021-2022 | |
| Antares Pharma, INC. | $107.93 | 2019-2025 | Xyosted |
| Pfizer INC. | $90.76 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marguerite Thomer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.